Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3
Meletios Α. Dimopoulos(National and Kapodistrian University of Athens), Morie A. Gertz(Mayo Clinic in Arizona), Mario Boccadoro(University of Turin), Jesús F. San Miguel(Universidad de Salamanca), Robert A. Kyle(Mayo Clinic in Arizona), Shaji Kumar(Mayo Clinic in Arizona), Sundar Jagannath(Mount Sinai Hospital), Heinz Ludwig(Wilhelminen Hospital), Kenneth C. Anderson(Novartis (Switzerland)), Seema Singhal(Northwestern University), Nikhil C. Munshi(Harvard University), Hartmut Goldschmidt(Heidelberg University), Hervé Avet‐Loiseau(Hôtel-Dieu de Paris), S. Vincent Rajkumar(Mayo Clinic), Sergio Giralt(Memorial Sloan Kettering Cancer Center), Meral Beksaç(Ankara University), Philippe Moreau(Institut Paoli-Calmettes), Douglas Joshua(Royal Prince Alfred Hospital), Jean-Paul Fermand(Hôpital Saint-Louis), Asher Chanan‐Khan(WinnMed), Jayesh Mehta(Northwestern University)
Cited by 450
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
|New England Journal of Medicine|2003|2.6k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k